21.09.2016

19th International Leprosy Congress with Swiss TPH as academic partner

The 19th International Leprosy Congress (ILC) is being held in Beijing from 18-21 September under the motto “Unfinished Business: stopping transmission, preventing disability, promoting inclusion”.

The 19th International Leprosy Congress (ILC) is being held in Beijing from 18-21 September under the motto “Unfinished Business: stopping transmission, preventing disability, promoting inclusion”. Leprosy was an early focus of disease-specific control efforts, and over 16 million leprosy patients have already completed multi-drug therapy. However, it remains the case that over 200,000 new leprosy patients are diagnosed every year, and morbidity management as well as social inclusion and socio-economic rehabilitation of leprosy patients continue to present huge challenges. Current research efforts focus on the interruption of leprosy transmission, e.g. with a single dose of rifampicin given to contacts of newly diagnosed leprosy patients. This approach is being assessed in the frame of the multi-partner Leprosy Post-Exposure Prophylaxis (LPEP) programme funded and coordinated by the Novartis Foundation.

 

Swiss TPH is one of the academic partners involved in this project. Dr. Peter Steinmann will present at ILC on the feasibility of contact tracing and chemoprophylaxis administration under different programmatic conditions. Dr. Tanja Barth-Jaeggi will examine the potential of chemoprophylaxis to reduce leprosy transmission, and present recommendations for the next phase of retrospective contact tracing in Cambodia.

 

More information on the conference is here: ciccst.org.cn/ILC2016/wel.html

 

To follow them on Twitter use: #ILC2016

zur Übersicht